VentiRx Pharmaceuticals Secures $19,352,414 New Financing Round

  • Feed Type
  • Date
    9/23/2014
  • Company Name
    VentiRx Pharmaceuticals
  • Mailing Address
    1191 Second Avenue Seattle, WA 98101 USA
  • Company Description
    VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
  • Website
    http://www.ventirx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $19,352,414
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy